For-Robin Therapeutics is an antibody immunotherapy company specializing in treating breast cancer. Its proprietary technology, the monoclonal antibody JAA-F11 and humanized variants of it, targets all breast cancer cell subtypes including triple negative breast cancer. In addition, this technology can be applicable to colon, prostate, and bladder carcinoma patient populations.